The invention provides methods to identify agents useful to prevent, inhibit or treat viral infections, e.g. filovirus infections, as well as compositions having one or more agents to prevent, inhibit or treat viral infection.
Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
- Madison WI, US Yasuko HATTA - Madison WI, US Pamuk Bilsel - Madison WI, US
Assignee:
FluGen, Inc. - Madison WI
International Classification:
A61K 39/145 C12N 7/00 A61K 39/295
Abstract:
Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include mutant M2 sequences, mutant BM2 sequences, and are useful in immunogenic compositions, e.g., as a quadrivalent vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
- Madison WI, US Yasuko Hatta - Madison WI, US Pamuk Bilsel - Madison WI, US Michael J. Moser - Madison WI, US
Assignee:
FluGen, Inc. - Madison WI
International Classification:
A61K 39/145 A61K 39/12 A61K 39/00 C12N 7/00
Abstract:
Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. The mutant viruses disclosed herein including a mutant M2 sequence are also useful to deliver antigens to a subject, e.g., to induce an immune response to the antigen. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
- Madison WI, US Yasuko Hatta - Madison WI, US Pamuk Bilsel - Madison WI, US Michael J. Moser - Madison WI, US
Assignee:
FluGen, Inc. - Madison WI
International Classification:
A61K 39/145 A61K 39/12 A61K 39/00 C12N 7/00
Abstract:
Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. The mutant viruses disclosed herein including a mutant M2 sequence are also useful to deliver antigens to a subject, e.g., to induce an immune response to the antigen. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
- Madison WI, US Yasuko Hatta - Madison WI, US Pamuk Bilsel - Madison WI, US
Assignee:
FluGen, Inc. - Madison WI
International Classification:
A61K 39/145 C12N 7/00 A61K 39/39 C07K 14/005
Abstract:
Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant BM2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
- Madison WI, US Yasuko HATTA - Madison WI, US Pamuk Bilsel - MADISON WI, US
Assignee:
FluGen, Inc. - Madison WI
International Classification:
A61K 39/145 A61K 39/295 C12N 7/00
Abstract:
Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include mutant M2 sequences, mutant BM2 sequences, and are useful in immunogenic compositions, e.g., as a quadrivalent vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.
Disclosed herein are compositions and methods related to mutant viruses, and in particular, mutant influenza viruses. The mutant viruses disclosed herein include a mutant M2 sequence, and are useful in immunogenic compositions, e.g., as vaccines. Also disclosed herein are methods, compositions and cells for propagating the viral mutants, and methods, devices and compositions related to vaccination.